Discover 3,590 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,590
Patient-Derived Xenografts to Reduce Cancer Health Disparities
for
Bladder Carcinoma, Gastric Carcinoma,
Location: Orange CA, Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 21 - 70+
Code: NCT04410302
Recruiting
Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects
for
Non Small Cell Lung Cancer
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT06221800
Recruiting
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
for
Relapsing Multiple Sclerosis
Location: Orange CA, Salt Lake City UT, Fort Collins CO,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT05877963
Phase 3, Recruiting
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas
for
Colon Adenocarcinoma, Colorectal Cancer
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT04920032
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
Location: Orange CA, Irvine CA, Cincinnati OH, West Chester OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06654037
Phase 1, Recruiting
New
PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratSystemicThe
for
Brain Cancer, Brain Cancer Metastatic, Nervous System Cancer,
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT07827001
Recruiting
New
Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial
for
Richter Syndrome,
Location: Orange CA, Irvine CA, Laguna Hills CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07220187
Phase 3, Recruiting
HIFU for Focal Ablation of Prostate Tissue: An Observational Study
for
Prostate Cancer
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: Male
Age: 40 - 70+
Code: NCT03620786
Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
for
Asthma
Location: Newport Beach CA, Bakersfield CA, San Jose CA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06932263
Phase 2, Recruiting
Intraoperative Electrically-evoked ABRs in Patients Undergoing Vestibular Schwannoma Surgery
for
Deafness
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18 - 70+
Code: NCT05248113
Recruiting
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
for
Psychosis Associated With Alzheimer's Disease
Location: Orange CA, Walnut Creek CA, Houston TX, Tampa FL,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 55 - 70+
Code: NCT05511363
Phase 3, Recruiting
Treatment of Meniere's Disease With Migraine Medications
for
Ménière
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 25 - 70+
Code: NCT05582837
Recruiting
New
Nerve Block for Severe Abdominal Pain in the Emergency Department
Location: Orange CA, San Diego CA, Houston TX, Rochester MN,
Sponsor: Medigus Ltd
Sex: All
Age: 18 - 70
Code: NCT02366169
Recruiting
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
for
B-cell Malignancy, Chronic Lymphocytic Leukemia,
Location: Orange CA, Houston TX, Milwaukee WI, Chicago IL,
Sponsor: Carna Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05602363
Phase 1, Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)